We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
-20.27%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$613K
AUM Growth
-$694M
Cap. Flow
-$229M
Cap. Flow %
-37,377.98%
Top 10 Hldgs %
43.1%
Holding
965
New
6
Increased
47
Reduced
75
Closed
214

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$23.5M
2
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$22.6M
3
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$18.8M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$14.3M
5
FBT icon
First Trust NYSE Arca Biotechnology Index Fund
FBT
+$14M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$49.3M
2
DTE icon
DTE Energy
DTE
+$17M
3
SBUX icon
Starbucks
SBUX
+$9.35M
4
BHF icon
Brighthouse Financial
BHF
+$8.94M
5
BNY
Bank of New York Mellon
BNY
+$8.69M

Sector Composition

Rank Sector Weight
1 Technology 10.3%
2 Healthcare 9.04%
3 Financials 7.22%
4 Consumer Staples 6.76%
5 Consumer Discretionary 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMCR icon
576
Amcor
AMCR
$21B
$3 ﹤0.01%
69
– –
AVB icon
577
AvalonBay Communities
AVB
$27.4B
$3 ﹤0.01%
23
– –
BAH icon
578
Booz Allen Hamilton
BAH
$8.53B
$3 ﹤0.01%
50
– –
CAL icon
579
Caleres
CAL
$428M
$3 ﹤0.01%
600
– –
CLLS
580
Cellectis
CLLS
$289M
$3 ﹤0.01%
304
– –
ELS icon
581
Equity Lifestyle Properties
ELS
$12.9B
$3 ﹤0.01%
56
– –
EQH.PRA icon
582
Equitable Holdings Series A Preferred Stock
EQH.PRA
$621M
$3 ﹤0.01%
200
– –
EQX icon
583
Equinox Gold
EQX
$6.93B
$3 ﹤0.01%
400
– –
EXPO icon
584
Exponent
EXPO
$3.24B
$3 ﹤0.01%
46
– –
FANG icon
585
Diamondback Energy
FANG
$55.9B
$3 ﹤0.01%
100
– –
FHI icon
586
Federated Hermes
FHI
$4.62B
$3 ﹤0.01%
165
– –
HMC icon
587
Honda
HMC
$40.1B
$3 ﹤0.01%
138
– –
HOG icon
588
Harley-Davidson
HOG
$2.59B
$3 ﹤0.01%
157
– –
HUYA
589
Huya Inc
HUYA
$568M
$3 ﹤0.01%
200
– –
KSS icon
590
Kohl's
KSS
$2.1B
$3 ﹤0.01%
200
– –
LZB icon
591
La-Z-Boy
LZB
$1.63B
$3 ﹤0.01%
147
– –
NVO
592
Novo Nordisk
NVO
$227B
$3 ﹤0.01%
104
– –
PACB icon
593
Pacific Biosciences
PACB
$435M
$3 ﹤0.01%
1,000
– –
PHG icon
594
Philips
PHG
$25.2B
$3 ﹤0.01%
82
– –
R icon
595
Ryder
R
$9.79B
$3 ﹤0.01%
100
– –
RCL icon
596
Royal Caribbean
RCL
$86.8B
$3 ﹤0.01%
100
– –
SAND
597
DELISTED
Sandstorm Gold
SAND
$3 ﹤0.01%
500
– –
SAR icon
598
Saratoga Investment
SAR
$312M
$3 ﹤0.01%
225
– –
SJM icon
599
J.M. Smucker
SJM
$13.5B
$3 ﹤0.01%
33
– –
SLV icon
600
iShares Silver Trust
SLV
$27.6B
$3 ﹤0.01%
200
– –
22 23
24
25 26

Similar funds

BFA
Brendel Financial Advisors Hanover, New Hampshire $202M AUM 37.99% 1-Year Est. Return
PCMK
Paragon Capital Management (Kansas) Overland Park, Kansas $202M AUM 26.44% 1-Year Est. Return
AFWM
Arta Finance Wealth Management Mountain View, California $202M AUM
PCM
Pointe Capital Management Grosse Pointe Farms, Michigan $202M AUM 17.2% 1-Year Est. Return
IFU
iSAM Funds (UK) London, United Kingdom $203M AUM 18.34% 1-Year Est. Return
MFG
Marmo Financial Group Johnson City, Tennessee $202M AUM 13.32% 1-Year Est. Return
GW
Griffith & Werner Canton, Georgia $202M AUM
RA
Riverstone Advisors New Braunfels, Texas $203M AUM 27.33% 1-Year Est. Return

tru Independence's Q1 2020 Portfolio in Review

As of Q1 2020, tru Independence held 965 positions worth $613K, down 100% from $695M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

tru Independence withdrew a net $229M in Q1 2020, closing 214 positions and reducing 75 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $49.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

Against the trend, tru Independence opened a new position in Norbord Inc. worth $3.02K.

  • tru Independence's largest Q1 2020 buy was Norbord Inc.: 254,795 shares worth $3.02K.
  • tru Independence added most to State Street SPDR S&P Biotech ETF in Q1 2020, an estimated $23.5M increase.
  • tru Independence's biggest Q1 2020 reduction was DTE Energy, cutting an estimated $17M.
  • tru Independence fully exited Bristol-Myers Squibb in Q1 2020, selling an estimated $49.3M.
  • tru Independence's ten largest holdings make up 43% of its $613K portfolio in Q1 2020.
  • tru Independence opened 6 new positions and closed 214 in Q1 2020.
  • tru Independence's portfolio value fell 100% quarter-over-quarter to $613K.

Based on tru Independence's 13F filing for Q1 2020, filed 19 May 2020.